Human Longevity

San Diego, CA · Founded 2013 · Privately Held (backing)

Developer of a biotechnology platform designed to combine genomic and phenotypic information to accelerate the understanding of human health. Human Longevity is based in San Diego, CA and was founded in 2013. Its last known valuation is $250 million. It has raised $1.1 billion across 3 recorded rounds; the latest was a $32 million early-stage round in Mar 2023.

Last price · $/share
—
Implied valuation
$250.0M
Total raised
$1.1B
Last round
Early Stage VC
Mar 2023
Cap table — not yet on record

Human Longevity's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Human Longevity with a free account
  • ·The complete investor list: 36 names
  • ·Watch Human Longevity: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Human Longevity

Where does Human Longevity's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Human Longevity's 3 recorded funding rounds.